Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 439, 391 (26 January 2006) | doi:10.1038/439391a; Published online 25 January 2006
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
- More Challenges
- Powered by:
nature jobs
Executive- Purchase (Raw Material)- Coporate Office
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Manager Brand Solutions
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
In brief
The US Food and Drug Administration last week agreed that potential flu drug peramivir can be fast-tracked through the approval process. Made by BioCryst Pharmaceuticals of Birmingham, Alabama, peramivir is an injectable drug that may be able to treat avian flu.
To read this story in full you will need to login or make a payment (see right).
